Scrip Regulatory Affairs
Spain passes generic policy-tightening decree affecting medtech and pharma
24 August 2011
Bernard Murphy
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Spain's austerity package decree to create cost-effectiveness committee for medicines
- UK PIP report highlights need to improve adverse incident reporting; registries urged
- French bill proposes heavy penal sanctions if medtech falls foul of marketing rules
- Brand vs generic: the battle rages over EU anti-counterfeit 'safety features'
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Other Informa Comments
